The DOI matches its Crossref record.
Growth‐inhibitory effect of quercetin and presence of type‐II estrogen‐binding sites in human colon‐cancer cell lines and primary colorectal tumors
Abstract
We studied the effect of quercetin (Q) on the proliferation of HT‐29, WiDr, COLO 201, and LS‐174T human colon cancer cell lines. Q, between 10 nM and 10 μM, exerted a dose‐dependent, reversible inhibition of cell proliferation. Cell‐cycle analysis revealed that the growth‐inhibitory effect of Q was due to a blocking action in the G 0/G 1 phase. Using a whole‐cell assay with 17β‐[3 H]‐estradiol as tracer, we demonstrated that all these cell lines contain type‐II estrogen‐binding sites (type‐II EBS). By using Q and other chemically related flavonols (3,7‐4′‐trimethox‐ yquercetin, 3,7,3,4′‐tetramethoxyquercetin, kaempferol, morin, and rutin), we observed that the affinities of these compounds for type‐II EBS are correlated with their growth‐inhibitory potential. Furthermore, the Q sensitivity of the colon cancer cell lines was correlated with the number of type‐II EBS/cell. Then Q could regulate colon cancer cell growth through a binding interaction with type‐ll EBS. This mechanism could also be active in vivo as we have observed that cytosolic type‐II EBS are present in primary colorectal cancers and that Q is effective in inhibiting the in vitro bromodeoxyuridine incorporated by neoplastic cells in these cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Middleton, E., Kandaswami, C., & Theoharides, T. C. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01472-8 · Cited by 4,882
The biochemistry and medical significance of the flavonoids
Havsteen, B. H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00298-x · Cited by 2,672
Hertog, M. G. L. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.1995.00430040053006 · Cited by 1,853
Hertog, M. G. L., Hollman, P. C. H., Katan, M. B., & Kromhout, D. (1993) · Nutrition and Cancer · doi:10.1080/01635589309514267 · Cited by 1,216
“Quercetin also inhibited proliferation of human colon cancer cells (11,12).”
BackgroundTherapeutic Potential of Quercetin: New Insights and Perspectives for Human Health
Salehi, B., Machin, L., Monzote, L., Sharifi-Rad, J., Ezzat, S. M., Salem, M. A., Merghany, R. M., El Mahdy, N. M., Kılıç, C. S., Sytar, O., et al. (2020) · ACS Omega · doi:10.1021/acsomega.0c01818 · Cited by 707
Antioxidant Compounds and Their Antioxidant Mechanism
Francenia Santos-Sánchez, N., Salas-Coronado, R., Villanueva-Cañongo, C., & Hernández-Carlos, B. (2019) · Antioxidants · doi:10.5772/intechopen.85270 · Cited by 594
Agullo, G., Gamet-Payrastre, L., Manenti, S., Viala, C., Rémésy, C., Chap, H., & Payrastre, B. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)82453-7 · Cited by 536
Ferreira, J. F. S., Luthria, D. L., Sasaki, T., & Heyerick, A. (2010) · Molecules · doi:10.3390/molecules15053135 · Cited by 531
So, F. V., Guthrie, N., Chambers, A. F., Moussa, M., & Carroll, K. K. (1996) · Nutrition and Cancer · doi:10.1080/01635589609514473 · Cited by 488
A Review of the Effects and Mechanisms of Polyphenolics in Cancer
Nichenametla, S. N., Taruscio, T. G., Barney, D. L., & Exon, J. H. (2006) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390591000541 · Cited by 444
Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential
Caltagirone, S., Rossi, C., Poggi, A., Ranelletti, F. O., Natali, P. G., Brunetti, M., Aiello, F. B., & Piantelli, M. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000815)87:4<595::aid-ijc21>3.0.co;2-5 · Cited by 437
Self-citationVidya Priyadarsini, R., Senthil Murugan, R., Maitreyi, S., Ramalingam, K., Karunagaran, D., & Nagini, S. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.09.020 · Cited by 399
Conjugation position of quercetin glucuronides and effect on biological activity
Day, A. J., Bao, Y., Morgan, M. R. A., & Williamson, G. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00416-0 · Cited by 375
Nguyen, T. T. T. (2003) · Carcinogenesis · doi:10.1093/carcin/bgh052 · Cited by 344
Conquer, J. A., Maiani, G., Azzini, E., Raguzzini, A., & Holub, B. J. (1998) · The Journal of Nutrition · doi:10.1093/jn/128.3.593 · Cited by 330
Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes
Wang, C., Mäkelä, T., Hase, T., Adlercreutz, H., & Kurzer, M. S. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90030-2 · Cited by 322
Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis
Mahmoud, N. N. (2000) · Carcinogenesis · doi:10.1093/carcin/21.5.921 · Cited by 317
Casagrande, F., & Darbon, J.-M. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00583-4 · Cited by 303
Dietary flavonoids and cancer risk in the Zutphen elderly study
Hertog, M. G. L., Feskens, E. J. M., Hollman, P. C. H., Katan, M. B., & Kromhout, D. (1994) · Nutrition and Cancer · doi:10.1080/01635589409514342 · Cited by 276
Scambia, G., Ranelletti, F. O., Panici, P. B., De Vincenzo, R., Bonanno, G., Ferrandina, G., Piantelli, M., Bussa, S., Rumi, C., Cianfriglia, M., et al. (1994) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00685655 · Cited by 271
Self-citationAlía, M., Mateos, R., Ramos, S., Lecumberri, E., Bravo, L., & Goya, L. (2006) · European Journal of Nutrition · doi:10.1007/s00394-005-0558-7 · Cited by 259
Liposomal Quercetin Efficiently Suppresses Growth of Solid Tumors in Murine Models
Yuan, Z.-P., Chen, L.-J., Fan, L.-Y., Tang, M.-H., Yang, G.-L., Yang, H.-S., Du, X.-B., Wang, G.-Q., Yao, W.-X., Zhao, Q.-M., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2365 · Cited by 254
Metadata
- Authors
- Ranelletti, F. O., Ricci, R., Larocca, L. M., Maggiano, N., Capelli, A., Scambia, G., Benedetti‐Panici, P., Mancuso, S., Rumi, C., & Piantelli, M.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1992-02
- Volume
- 50
- Issue
- 3
- Pages
- 486-492
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2079457273
- Cited by
- 169
- References
- 0
- FWCI
- 7.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.